Arachidonyl trifluoromethyl ketone induces lipid body formation in leukocytes

被引:12
作者
Bozza, PT
Weller, PF
机构
[1] Harvard Univ, Sch Med, Beth Israel Deaconess Med Ctr, Harvard Thorndike Lab, Boston, MA 02215 USA
[2] Harvard Univ, Sch Med, Beth Israel Deaconess Med Ctr, Dept Med,Charles A Dana Res Inst, Boston, MA 02215 USA
[3] Inst Oswaldo Cruz, Dept Physiol & Phamracodynam, Immunopharmacol Lab, BR-20001 Rio De Janeiro, Brazil
来源
PROSTAGLANDINS LEUKOTRIENES AND ESSENTIAL FATTY ACIDS | 2001年 / 64卷 / 4-5期
关键词
D O I
10.1054/plef.2001.0264
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Leukocyte lipid bodies, abundant in cells associated with inflammation, can be induced to form in response to stimuli that include cis-unsaturated, but not saturated, fatty acids. Arachidonyl trifluoromethyl ketone (AACOCF(3)), a non-esterifiable arachidonate analog and an inhibitor of cytosolic phospholipase A(2) enzymes (PLA(2)), dose-dependently (0-20 muM) stimulated neutrophil lipid body formation, but this stimulation was not attributable to PLA(2) inhibition. Palmitoyl trifluoromethyl ketone, also a PLA(2) inhibitor, failed to stimulate lipid body formation, like palmitic acid itself, and did not inhibit stimulated lipid body formation. Moreover, aspirin, indomethacin and ibuprofen, which inhibit cis-unsaturated fatty acid-induced lipid body formation, inhibited AACOCF(3)-induced lipid body formation. Lipid body induction with AACOCF(3) reflected its structural basis as a cis-unsaturated fatty acid analog. These results indicate that cytosolic PLA(2) enzymes are not active in lipid body induction and cis-fatty acid stimulation of lipid body formation does not require esterification of cis-fatty acids into glycerolipids. (C) 2001 Harcourt Publishers Ltd.
引用
收藏
页码:227 / 230
页数:4
相关论文
共 19 条